Predictive Genetic Testing and Consumer Genomics Market Size, Trends, Analysis, and Outlook By Test (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Breast & Ovarian Cancer, Cardiovascular screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism / Alzheimer’s Disease, Urologic screening/ Prostate cancer screening, Orthopedic & Musculoskeletal, Others), By Setting Type (DTC, Professional), by Region, Country, Segment, and Companies, 2024-2030
The global Predictive Genetic Testing and Consumer Genomics market size is poised to register 13.82% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Predictive Genetic Testing and Consumer Genomics market across By Test (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Breast & Ovarian Cancer, Cardiovascular screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism / Alzheimer’s Disease, Urologic screening/ Prostate cancer screening, Orthopedic & Musculoskeletal, Others), By Setting Type (DTC, Professional).
The Predictive Genetic Testing and Consumer Genomics Market is witnessing growth driven by increasing consumer interest in personalized healthcare, expanding applications of genetic testing in disease risk assessment, and advancements in genomic sequencing technologies. Predictive genetic testing and consumer genomics services offer insights into individuals' genetic predispositions to certain diseases, traits, and drug responses, enabling proactive health management and lifestyle interventions. Key trends include the development of direct-to-consumer genetic testing kits for home use and online genetic counseling services, expansion of genetic testing menus to include ancestry analysis and wellness assessments, and integration of genetic data with electronic health records and digital health platforms. Moreover, increasing public awareness of genetics and genomics, expansion of genetic testing regulations and oversight, and collaborations between genetic testing companies and healthcare providers contribute to market growth.
Predictive Genetic Testing and Consumer Genomics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Predictive Genetic Testing and Consumer Genomics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Predictive Genetic Testing and Consumer Genomics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Predictive Genetic Testing and Consumer Genomics industry.
Key market trends defining the global Predictive Genetic Testing and Consumer Genomics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Predictive Genetic Testing and Consumer Genomics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Predictive Genetic Testing and Consumer Genomics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Predictive Genetic Testing and Consumer Genomics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Predictive Genetic Testing and Consumer Genomics industry
Leading Predictive Genetic Testing and Consumer Genomics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Predictive Genetic Testing and Consumer Genomics companies.
Predictive Genetic Testing and Consumer Genomics Market Study- Strategic Analysis Review
The Predictive Genetic Testing and Consumer Genomics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Predictive Genetic Testing and Consumer Genomics Market Size Outlook- Historic and Forecast Revenue in Three Cases
The Predictive Genetic Testing and Consumer Genomics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Predictive Genetic Testing and Consumer Genomics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Predictive Genetic Testing and Consumer Genomics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Predictive Genetic Testing and Consumer Genomics market segments. Similarly, Strong end-user demand is encouraging Canadian Predictive Genetic Testing and Consumer Genomics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Predictive Genetic Testing and Consumer Genomics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Predictive Genetic Testing and Consumer Genomics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Predictive Genetic Testing and Consumer Genomics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Predictive Genetic Testing and Consumer Genomics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Predictive Genetic Testing and Consumer Genomics in Asia Pacific. In particular, China, India, and South East Asian Predictive Genetic Testing and Consumer Genomics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Predictive Genetic Testing and Consumer Genomics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Predictive Genetic Testing and Consumer Genomics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Predictive Genetic Testing and Consumer Genomics.
Predictive Genetic Testing and Consumer Genomics Market Company Profiles
The global Predictive Genetic Testing and Consumer Genomics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories Inc, Agilent Technologies Inc, ARUP Laboratories, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Illumina Inc, Myriad Genetics Inc, Taysha GTx, Thermo Fisher Scientific
Recent Predictive Genetic Testing and Consumer Genomics Market Developments
The global Predictive Genetic Testing and Consumer Genomics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Predictive Genetic Testing and Consumer Genomics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
Market Segmentation:
By Test
Predictive Testing
-Genetic Susceptibility Test
-Predictive Diagnostics
-Population Screening
Consumer Genomics
Wellness Genomics
-Nutria Genetics
-Skin & Metabolism Genetics
-Others
By Application
Predictive Genetic Testing & Consumer Genomics
-Breast & Ovarian Cancer
-Cardiovascular screening
-Diabetic Screening & Monitoring
-Colon Cancer
-Parkinsonism / Alzheimer’s Disease
-Urologic screening/ Prostate cancer screening
-Orthopedic & Musculoskeletal
-Others
By Setting Type
DTC
Professional
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Companies
Abbott Laboratories Inc
Agilent Technologies Inc
ARUP Laboratories
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Illumina Inc
Myriad Genetics Inc
Taysha GTx
Thermo Fisher Scientific
Formats Available: Excel, PDF, and PPT